Option chain shows key data for BioLife Solutions's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for BioLife Solutions.

BioLife Solutions (NASDAQ:BLFS) Stock, Option Chain

BIOLIFE SOLUTIONS INC

BioLife Solns

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions

Earnings

News

Small Cap

Markets

Trading Ideas

BLFS

Boston Scientific (NYSE: BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.

Boston Scientific Q1 Earnings and Revenues Top Estimates

Meta Platforms - logo

Short Ideas

Insider Trades

PSTG

SCVL

Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling

Long Ideas

Pre-Market Outlook

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buying

BioLife Solutions Inc

Press Releases

BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations

BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025

BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results

BioLife Solutions Appoints Cathy Coste as Director and Audit Committee Chair

BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company

BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025

BioLife Solutions Reports First Quarter 2025 Financial Results

BioLife Solutions Updates Earnings Call Information

RGEN

Agilent Technologies

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share